Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $9.9 million.

  • Dna X's Non-Current Assets fell 3510.44% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year decrease of 3391.46%. This contributed to the annual value of $7.6 million for FY2024, which is 3820.17% down from last year.
  • Latest data reveals that Dna X reported Non-Current Assets of $9.9 million as of Q3 2025, which was down 3510.44% from $9.0 million recorded in Q2 2025.
  • Dna X's 5-year Non-Current Assets high stood at $15.3 million for Q3 2024, and its period low was $2.4 million during Q4 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $9.0 million (2025), whereas its average is $8.5 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 5784.99% in 2021, then surged by 18949.37% in 2022.
  • Over the past 5 years, Dna X's Non-Current Assets (Quarter) stood at $2.4 million in 2021, then soared by 189.49% to $6.9 million in 2022, then soared by 78.63% to $12.3 million in 2023, then plummeted by 38.2% to $7.6 million in 2024, then surged by 30.95% to $9.9 million in 2025.
  • Its Non-Current Assets stands at $9.9 million for Q3 2025, versus $9.0 million for Q2 2025 and $9.0 million for Q1 2025.